Form 8-K - Current report:
SEC Accession No. 0000950142-22-000881
Filing Date
2022-03-03
Accepted
2022-03-03 17:23:57
Documents
13
Period of Report
2022-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh220231317_8k.htm   iXBRL 8-K 32743
2 EXHIBIT 3.1 eh220231317_ex0301.htm EX-3.1 136621
  Complete submission text file 0000950142-22-000881.txt   378162

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vtvt-20220227.xsd EX-101.SCH 3054
4 XBRL LABEL FILE vtvt-20220227_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE vtvt-20220227_pre.xml EX-101.PRE 22609
7 EXTRACTED XBRL INSTANCE DOCUMENT eh220231317_8k_htm.xml XML 3725
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 22710409
SIC: 2834 Pharmaceutical Preparations